The Tumour Panel (Female) blood test analyzes various biomarkers associated with female cancers, including breast, ovarian, and cervical cancer. It aids in early detection, monitoring treatment response, and detecting cancer recurrence, guiding personalized treatment plans for improved outcomes in women's health.

Tumour Panel ( Female )

The CEA (Carcinoembryonic Antigen) blood test measures levels of CEA, a protein produced by certain cancerous cells. Elevated CEA levels may indicate the presence of cancers, particularly in the colon, rectum, or other gastrointestinal organs. This test aids in cancer diagnosis, monitoring, and treatment evaluation.

CEA -  Carcinoembryonic Antigen

The CA 125 blood test measures Cancer Antigen 125 (CA 125) levels in the blood. CA 125 is a protein marker associated with ovarian cancer, though it can also be elevated in other conditions. Monitoring CA 125 levels aids in diagnosing ovarian cancer, assessing treatment response, and detecting recurrences.

CA 125 - Cancer Antigen 125

The CA 15-3 blood test measures Cancer Antigen 15-3 (CA 15-3) levels in the blood. CA 15-3 is a tumor marker primarily used to monitor breast cancer progression and treatment response. Elevated CA 15-3 levels may indicate breast cancer recurrence or metastasis, guiding further diagnostic and therapeutic interventions.

CA 15.3 - Cancer Antigen 15.3

AFP (Alpha-fetoprotein) blood test measures the level of AFP in the blood. Elevated AFP levels may indicate liver diseases, certain cancers (such as liver cancer and germ cell tumors), or neural tube defects in infants. It's often used as a tumor marker for diagnosing and monitoring cancers.

AFP - Alpha Fetoprotein

CA 19.9 - Cancer Antigen 19.9

The Beta HCG (Quantitative) blood test measures the exact amount of human chorionic gonadotropin (HCG) hormone in the blood. It's used to monitor pregnancy progression, detect abnormalities like ectopic pregnancy, or screen for certain cancers. Quantitative results provide specific HCG levels, aiding in diagnosis and treatment decisions.

‌

CEA - Carcinoembryonic Antigen -

CA 125 - Cancer Antigen 125 -

CA 15.3 - Cancer Antigen 15.3 -

AFP - Alpha Fetoprotein -

CA 19.9 - Cancer Antigen 19.9 -

Beta HCG (Quantitative) - Maternal -

Why choose Curelo?